John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 50,000 shares at $36.00 ($1.8M) on 2020-11-25, disclosed to the SEC on 2020-11-25.
Open-market sale of $1.8M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |